ALLARITY THERAPEUTIC

ALLR
Delayed Quote. Delayed  - 10/18 03:21:11 am
1.632SEK -1.63%

Turn to zoom
Prev.1.6590
Open1.6590
High1.6790
Low1.6390
Volume2 984 137
Latest news
09/24
09/23
09/16
09/16
Chart ALLARITY THERAPEUTICS A/S
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance1,802,442,28
Spread/Res.-8,5%-32%-28%
Spread/Supp.19%19%34%
Support1,391,391,23
Financials
Sales 2021 - - -
Net income 2021 -98,2 M -11,4 M -11,4 M
Net cash 2021 27,2 M 3,15 M 3,15 M
P/E ratio 2021 -4,27x
Yield 2021 -
Capitalization 670 M 77,8 M 77,6 M
EV / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 14
Free-Float 83,0%
Company
Allarity Therapeutics A/S, formerly known as ONCOLOGY VENTURE A/S, is a Danmark-based company engaged in the development of anticancer medicines. The Company s current priority program focus is on the advancement of three precision medicine treatments: 2X-121, Dovitinib and Ixempra targeting the...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-11-30 Earnings Release

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 1,66 
Average target price
Spread / Average Target -